Association of Baseline Comorbidities With First-Year Adherence to GLP-1 Receptor Agonists in Patients With Diabetes or Obesity: A Retrospective Cohort Study
{{output}}
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used for diabetes and obesity. Yet, the role of comorbidities on adherence, and variability due to drug subtype or indication remains understudied... ...
